Close Menu

NEW YORK (GenomeWeb) – The American Society of Clinical Oncology and precision medicine firm Tempus have agreed to work together in support of ASCO's Targeted Agent and Profiling Utilization (TAPUR) Study.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.